Deutsch English Français

Contact

EP3328417

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP3328417

EP3328417 - MYCOBACTERIUM LYSTERASE: A NOVEL TREATMENT FOR ACNE [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 15.01.2021 Database last updated on 19.10.2024
Former	Examination is in progress Status updated on 01.05.2020
Former	Request for examination was made Status updated on 04.05.2018
Former	The international publication has been made Status updated on 11.02.2017
Most recent event Tooltip	15.01.2021	Application deemed to be withdrawn	published on 17.02.2021 [2021/07]
Applicant(s)	For all designated states The Regents of the University of California 1111 Franklin Street, 12th Floor Oakland, CA 94607 / US
	For all designated states University of Pittsburgh - Of the Commonwealth System of Higher Education 200 Gardner Steel Conference Center Thackeray & O'Hara Streets Pittsburgh, PA 15260 / US
	[2018/23]
Inventor(s)	01 / MODLIN, Robert, L. 4034 Benedict Canyon Drive Sherman Oaks, CA 91423 / US
	02 / HATFULL, Graham, F. 1529 Jenkins Drive Pittsburgh, PA 15241 / US
	03 / BARBEAU, Dominique, J. 4249 Fifth Avenue Pittsburgh, PA 15260 / US
	04 / OJHA, Anil, K. 55 Gullane Drive Slingerlands, N.Y. 12159 / US
	[2018/23]
Representative(s)	Müller-Boré & Partner Patentanwälte PartG mbB Friedenheimer Brücke 21 80639 München / DE
	[2018/23]
Application number, filing date	16833563.6	28.07.2016
	[2018/23]
	WO2016US44427
Priority number, date	US201562199674P	31.07.2015 Original published format: US 201562199674 P
	[2018/23]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2017023680
	Date:	09.02.2017
	Language:	EN
	[2017/06]
	Type:	A1 Application with search report
	No.:	EP3328417
	Date:	06.06.2018
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 09.02.2017 takes the place of the publication of the European patent application.
	[2018/23]
Search report(s)	International search report - published on:	IL	09.02.2017
	(Supplementary) European search report - dispatched on:	EP	08.01.2019
Classification	IPC:	A61K38/43, A61K9/06, A61K47/10, A61P17/10	[2018/23]
	CPC:	A61K38/47 (EP,US); A61K38/162 (EP,US); A61K47/02 (US); A61K47/10 (EP,US); A61K9/0014 (EP,US); A61P17/10 (EP,US); (+) C12Y302/01017 (EP,US); C12Y302/0117 (EP,US) (-)
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/23]
Title	German:	MYCOBACTERIUM LYSTERASE: EINE NEUARTIGE BEHANDLUNG FÜR AKNE	[2018/23]
	English:	MYCOBACTERIUM LYSTERASE: A NOVEL TREATMENT FOR ACNE	[2018/23]
	French:	MYCOBACTERIUM LYSTÉRASE : UN NOUVEAU TRAITEMENT CONTRE L'ACNÉ	[2018/23]
Entry into regional phase	22.02.2018	National basic fee paid
	22.02.2018	Search fee paid
	22.02.2018	Designation fee(s) paid
	22.02.2018	Examination fee paid
Examination procedure	19.02.2018	Date on which the examining division has become responsible
	22.02.2018	Examination requested [2018/23]
	24.07.2019	Amendment by applicant (claims and/or description)
	07.05.2020	Despatch of a communication from the examining division (Time limit: M04)
	18.09.2020	Application deemed to be withdrawn, date of legal effect [2021/07]
	12.10.2020	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2021/07]
Fees paid	Renewal fee
	27.07.2018	Renewal fee patent year 03
	29.07.2019	Renewal fee patent year 04
	27.07.2020	Renewal fee patent year 05
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[IP]CN105275112 ;
		[I] - SCHLIEVERT P ET AL, "Amniotic fluid antibacterial mechanisms: newer concepts", SEMINARS IN PERINATOLOGY, W.B. SAUNDERS, GB, (19761231), vol. 1, no. 1, ISSN 0146-0005, pages 59 - 70, XP009509986 [I] 1-15 cf. page 62, 2nd para. of the left-side col., summary at page 67
		[I] - HOU LILI ET AL, "[Expression and purification of lysin B in mycobacteriophage D29 and analysis of its enzymatic properties].", MEDLINE, US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US, (201004), Database accession no. NLM20575441, XP009509985 [I] 1-15 * abstract *
		[ ] - HOU LILI ET AL, "[Expression and purification of lysin B in mycobacteriophage D29 and analysis of its enzymatic properties].", SHENG WU GONG CHENG XUE BAO = CHINESE JOURNAL OF BIOTECHNOLOGY APR 2010, (201004), vol. 26, no. 4, ISSN 1000-3061, pages 517 - 522
		[IP] - DATABASE WPI, 0, Derwent World Patents Index, vol. 2016, no. 11, Database accession no. 2016-08739E, XP002787422 & CN105275112 A 20160127 (UNIV TIANJIN CHENGJIAN) [IP] 1-15 * abstract *
		[Y] - M. D. FARRAR ET AL, "Genome Sequence and Analysis of a Propionibacterium acnes Bacteriophage", JOURNAL OF BACTERIOLOGY, (20070330), vol. 189, no. 11, doi:10.1128/JB.00106-07, ISSN 0021-9193, pages 4161 - 4167, XP055208234 [Y] 1-15 cf. abstract, discussion part at page 4166 DOI: http://dx.doi.org/10.1128/JB.00106-07
		[Y] - PAYNE K ET AL, "Mycobacteriophage Lysin B is a novel mycolylarabinogalactan esterase", MOLECULAR MICROBIOLOGY, WILEY-BLACKWELL PUBLISHING LTD, GB, vol. 73, no. 3, doi:10.1111/J.1365-2958.2009.06775.X, ISSN 0950-382X, (20090801), pages 367 - 381, (20090622), XP002741811 [Y] 1-15 cf. summary DOI: http://dx.doi.org/10.1111/j.1365-2958.2009.06775.x
		[Y] - KIMBERLY M. PAYNE ET AL, "Mycobacteriophage Endolysins: Diverse and Modular Enzymes with Multiple Catalytic Activities", PLOS ONE, (20120101), vol. 7, no. 3, doi:10.1371/journal.pone.0034052, ISSN 1932-6203, page e34052, XP055041651 [Y] 1-15 cf. abstract, 3rd para. of the left col. at page 12 DOI: http://dx.doi.org/10.1371/journal.pone.0034052
	International search	[Y]WO2012145630 (UNIV ROCKEFELLER [US], et al) [Y] 10-13, 18-26* abstract, claim 34, paragraphs [00189], [0096], [0228], [0055] *;
		[XY]WO2014001572 (LYSANDO AG [LI]) [X] 1-9, 14-17 * claim 2,3, page 28 first paragraph claim 2,3, page 28 first paragraph * [Y] 1-27;
		[XY] - KIMBERLY MARIE PAYNE, "Mycobacteriophage lysins: Bioinformatic characterization of the function of lysine A and identification of the function of lysin B in infection", PhD, (20100930), page 73, XP055362787 [X] 1-9, 14-17, 27 * third paragraph, page 280, page 283 secound paragraph, page 147, Figure 28). page 73 third paragraph, page 280, page 283 secound paragraph. * [Y] 1-27
		[Y] - MARINELLI LJ et al., Propionibacterium acnes bacteriophages display limited genetic diversity and broad killing activity against bacterial skin isolates, (20120925), page 10, XP055362789 [Y] 1-3, 14-17 * right column * DOI: http://dx.doi.org/10.1128/mBio.00279-12

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p